Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Economics of Cancer Care
Patients with Cancer Are Not Asking for Low-Value Tests or Therapies
By
Wayne Kuznar
Economics & Value
,
Economics of Cancer Care
August 2014, Vol 5, No 6
Chicago, IL—Contrary to common belief, there appears to be little demand on the part of patients with cancer for unsuitable, high-cost, low-value tests or therapies.
Read Article
Most Hospital Readmissions Not Preventable for Patients with Cancer
By
Wayne Kuznar
Economics & Value
,
Economics of Cancer Care
August 2014, Vol 5, No 6
Chicago, IL—Hospital readmissions in patients with cancer reflect the high burden of this disease, which is often refractory and, therefore, readmission is not reasonably preventable.
Read Article
Oncologists Want More Education on How to Discuss Cost of Treatment with Patients
Economics & Value
,
Economics of Cancer Care
August 2014, Vol 5, No 6
Chicago, IL—Oncologists responding to a national electronic survey believe that discussing out-of-pocket (OOP) costs of therapy with patients is important, and that OOP costs and societal cost of therapy will play a larger role in cancer treatment decisions over the next 5 years.
Read Article
Even When Adjusting for Improved Survival, Newer Anticancer Drugs Are More Expensive than Older Ones
By
Wayne Kuznar
Economics & Value
,
Economics of Cancer Care
August 2014, Vol 5, No 6
Chicago, IL—Even after adjusted for improved outcomes, newer anticancer drugs are more expensive than older agents, said Rena Conti, PhD, Assistant Professor of Health Policy and Economics, University of Chicago, at the 2014 American Society of Clinical Oncology meeting.
Read Article
Medication Costs Impact Patient Adherence Even in Oncology, Affecting Quality Care
By
Eileen Koutnik-Fotopoulos
Economics of Cancer Care
August 2014, Vol 5, No 6
Nonadherence to medication has been associated with financial burden; however, little is known about the association between the discussion of cancer treatments between patients and oncologists regarding out-of-pocket cost and medication adherence.
Read Article
Dabrafenib-Trametinib Combination Projected to Improve Survival at Increased Cost versus Other First-Line Therapies in Metastatic Melanoma
By
Alice Goodman
Economics & Value
,
Economics of Cancer Care
June 2014, Vol 5, No 5
Tampa, FL—Combining dabrafenib (Tafinlar) with trametinib (Mekinist) as upfront treatment for patients diagnosed with
BRAF V600
mutation–positive metastatic melanoma should lead to improved survival, but it increases the direct costs of treatment compared with other first-line therapies.
Read Article
Insurance Coverage for Genetic Testing and Personalized Medicine: Which Way Is the Wind Blowing?
By
Alice Goodman
Economics & Value
,
Economics of Cancer Care
June 2014, Vol 5, No 5
Tampa, FL—Genetic testing and targeted medicines, the key players in personalized medicine, are seen as the waves of the future for managing patients with cancer, but getting there remains a challenge when it comes to insurance coverage for these expensive tests and therapies.
Read Article
Aetna’s Model of Value-Based, Financially Viable Accountable Care Improves Health Outcomes
By
Rosemary Frei, MSc
Economics & Value
,
Economics of Cancer Care
June 2014, Vol 5, No 5
Charles Kennedy, MD, Chief Executive Officer of Aetna’s Accountable Care Solutions, is responsible for leading Aetna’s accountable care partnerships with healthcare providers. Dr Kennedy also serves as the health insurance industry representative on the Health IT Policy Committee, a federal advisory committee that makes recommendations to the National Coordinator for Health IT on a policy framework for the development and adoption of a nationwide health information infrastructure.
Read Article
Frequent Mammography Screening for Breast Cancer Adds Billions to Cost
By
Rosemary Frei, MSc
Economics & Value
,
Economics of Cancer Care
May 2014, Vol 5, No 4
The total annual cost of mammography screening for women aged 40 to 85 years in the United States is estimated to be $7.8 billion, according to a new analysis (O’Donoghue C, et al.
Ann Intern Med
. 2014;160:145-153). That is $4.3 billion more than the cost would be if mammography intervals were lowered to fall in line with the recommendations of the US Preventive Services Task Force (USPSTF), the study researchers calculated.
Read Article
Challenges Facing US Cancer Care in 2014: ASCO’s First Annual Report to the Nation
By
Eileen Koutnik-Fotopoulos
Economics & Value
,
Economics of Cancer Care
May 2014, Vol 5, No 4
Advances in cancer treatment, from detection and diagnosis to drugs, surgical techniques, and new imaging capabilities, have collectively enabled many patients to live longer, healthier lives with or after cancer. However, a new landmark report, “The State of Cancer Care in America, 2014: A Report by the American Society of Clinical Oncology” (ASCO), identifies the many challenges that will impact the future delivery of cancer care (ASCO.
J Oncol Pract
. 2014;10:119-143). These challenges include an increasing demand for care, predicted workforce shortages, rapidly rising costs, imbalances in access to care, and an unstable practice environment.
Read Article
Page 4 of 9
1
2
3
4
5
6
7
8
9
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma